Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia
Irnizarifka Irnizarifka
2Division of Heart Failure, Arrythmia, and Cardiac Pacing, Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Outcomes of True Zero-Fluoroscopy Catheter Ablation for Atrial Fibrillation Care: A Systematic Review and Meta-analysis Nathania Ella Sudiono; Christopher Daniel Tristan; Muhammad Farid Hamka; Erlangga Masykur Kynaya; Awalil Rifqi Kurnia Rahman; Irnizarifka Irnizarifka
JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Vol 12 No 3 (2026): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Vol. 12.3 (2026)
Publisher : BAPIN-ISMKI (Badan Analisis Pengembangan Ilmiah Nasional - Ikatan Senat Mahasiswa Kedokteran Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53366/jimki.v12i3.1103

Abstract

Introduction: Atrial fibrillation (AF) represents the most common arrhythmia. Current guidelines recommending catheter ablation as first-line rythm control and definitive treatment for AF which resistant or unresponsive to antiarrhythmic drugs. However, there is concerning issue of fluoroscopy radiation regarding conventional catheter ablation. Zero-fluoroscopy (ZF) emerged as novel technique to fully eliminated fluoroscopy with uncertainity of efficacy and safety. Previous review was insufficient, as they grouped fluoroless ablation under the ZF category. Method: Scopus, Pubmed, ScienceDirect, and CENTRAL were used to identify relevant studies prior to December 21, 2024. Studies directly comparing TZF vs NZF were included. Quality assessment was carried out using the RoB 2.0 and ROBINS-I tool. Meta-analysis was conducted using R-Studio. Discussion: There were one randomized controlled trial (RCT) and seven non-randomized cohorts (1.171 patients) included. The success of pulmonary vein isolation (PVI) with TZF and NZF was comparable, with follow-up visits showing equivalent AF recurrence rates at 6 months (RR = 1.00; 95% CI = 0.90 - 1.11; p = 0.99) and 12 months (RR = 0.57; 95% CI = 0.13 – 2.57; p = 0.47). ZF showed a significantly shorter procedural time duration (MD = -8.94; 95% CI = -13.56 – (-4.32); p < 0.01). Safety evaluation of ZF demonstrated comparable results for cardiac tamponade (RR = 1.77; 95% CI = 0.37 – 8.37; p = 0.47) and other adverse events risk. Conclusion: TZF technique in catheter ablation for AF is a revolutionary, effective, and safe innovation. TZF should be considered the standard approach in AF catheter ablation.
Co-Authors Awalil Rifqi Kurnia Rahman Christopher Daniel Tristan Erlangga Masykur Kynaya Muhammad Farid Hamka Nathania Ella Sudiono